The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy
Open accessAbstract
OBJECTIVE—The aim of this trial was to evaluate the effects of α-lipoic acid (ALA) on positive sensory symptoms and neuropathic deficits in diabetic patients with distal symmetric polyneuropathy (DSP). RESEARCH DESIGN AND METHODS—In this multicenter, randomized, double-blind, placebo-controlled trial, 181 diabetic patients in Russia and Israel received once-daily oral doses of 600 mg (n = 45) (ALA600), 1,200 mg (n = 47) (ALA1200), and 1,800 mg (ALA1800) of ALA (n = 46) or placebo (n = 43) for 5 weeks after a 1-week placebo run-in period. The primary outcome measure was the change from baseline of the Total Symptom Score (TSS), including stabbing pain, burning pain, paresthesia, and asleep numbness of the feet. Secondary end points included individual symptoms of TSS, Neuropathy Symptoms and Change (NSC) score, Neuropathy Impairment Score (NIS), and patients’ global assessment of efficacy. RESULTS—Mean TSS did not differ significantly at baseline among the treatment groups and on average decreased by 4.9 points (51%) in ALA600, 4.5 (48%) in ALA1200, and 4.7 (52%) in ALA1800 compared with 2.9 points (32%) in the placebo group (all P < 0.05 vs. placebo). The corresponding response rates (≥50% reduction in TSS) were 62, 50, 56, and 26%, respectively. Significant improvements favoring all three ALA groups were also noted for stabbing and burning pain, the NSC score, and the patients’ global assessment of efficacy. The NIS was numerically reduced. Safety analysis showed a dose-dependent increase in nausea, vomiting, and vertigo. CONCLUSIONS—Oral treatment with ALA for 5 weeks improved neuropathic symptoms and deficits in patients with DSP. An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationAlgorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Vincent, A. M., Russell, J. W., Low, P., & Feldman, E. L. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0019 · Cited by 982
Self-citationBoulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life
Galer, B. S., Gianas, A., & Jensen, M. P. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00112-6 · Cited by 601
Detection, characterization, and staging of polyneuropathy: Assessed in diabetics
Dyck, P. J. (1988) · Muscle & Nerve · doi:10.1002/mus.880110106 · Cited by 555
Self-citationTreatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis
Ziegler, D., Nowak, H., Kempler, P., Vargha, P., & Low, P. A. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01109.x · Cited by 551
Self-citationZiegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Self-citationDaousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Abbott, C. A., Vileikyte, L., Williamson, S., Carrington, A. L., & Boulton, A. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1071 · Cited by 399
Nagamatsu, M., Nickander, K. K., Schmelzer, J. D., Raya, A., Wittrock, D. A., Tritschler, H., & Low, P. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1160 · Cited by 378
Self-citationThe Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid
The SYDNEY Trial Authors, F. T. S. T. S. G., Ametov, A. S., Barinov, A., Dyck, P. J., Hermann, R., Kozlova, N., Litchy, W. J., Low, P. A., Nehrdich, D., Novosadova, M., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.770 · Cited by 359
Self-citationCoppey, L. J., Gellett, J. S., Davidson, E. P., Dunlap, J. A., Lund, D. D., & Yorek, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1927 · Cited by 300
Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Möller, W., Tritschler, H.-J., & Mehnert, H. (1999) · Free Radical Research · doi:10.1080/10715769900300721 · Cited by 283
Sola, S., Mir, M. Q. S., Cheema, F. A., Khan-Merchant, N., Menon, R. G., Parthasarathy, S., & Khan, B. V. (2005) · Circulation · doi:10.1161/01.cir.0000153272.48711.b9 · Cited by 282
Dyck, P. J., Karnes, J. L., O'Brien, P. C., Litchy, W. J., Low, P. A., & Melton, L. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1164 · Cited by 245
Self-citationHeitzer, T. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00551-2 · Cited by 194
Ziegler, D., Sohr, C. G. H., & Nourooz-Zadeh, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2178 · Cited by 183
Self-citationRuhnau, K. ‐., Meissner, H. P., Finn, J. ‐., Reljanovic, M., Lobisch, M., Schütte, K., Nehrdich, D., Tritschler, H. J., Mehnert, H., & Ziegler, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00190.x · Cited by 178
Self-citationCameron, N. E., Cotter, M. A., Horrobin, D. F., & Tritschler, H. (1998) · Diabetologia · doi:10.1007/s001250050921 · Cited by 156
Borcea, V., Nourooz‐Zadeh, J., Wolff, S. P., Klevesath, M. S., Hofmann, M. A., Urich, H., Wahl, P. M., Ziegler, R., Tritschler, H., Halliwell, B. B., et al. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00011-8 · Cited by 141
Thioctic Acid for Patients with Symptomatic Diabetic Polyneuropathy: A Critical Review
Ziegler, D. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403030-00005 · Cited by 135
Self-citationBril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Coppini, D. V., Bowtell, P., Weng, C., Young, P. J., & Sönksen, P. H. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00170-5 · Cited by 123
Textbook of Diabetic Neuropathy
Gries, F., Cameron, N., Ziegler, D., Andersen, H., Arezzo, J. C., Baynes, J., Biessels, G. J., Bolli, G. B., Bottini, P., Boulton, A. J. M., et al. (2003) · Thieme eBooks · doi:10.1055/b-002-85461 · Cited by 98
Self-citationAlpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve
Mitsui, Y., Schmelzer, J. D., Zollman, P. J., Mitsui, M., Tritschler, H., & Low, P. A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00017-9 · Cited by 88
Self-citationKunt, T., Forst, T. M., Wilhelm, A., Tritschler, H., PFUETZNER, A., Harzer, O., Engelbach, M., ZSCHAEBITZ, A., Stofft, E., & Beyer, J. (1999) · Clinical Science · doi:10.1042/cs0960075 · Cited by 87
Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy
Haak, E., Usadel, K. H., Kusterer, K., Amini, P., Frommeyer, R., Tritschler, H., & Haak, T. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-7739 · Cited by 74
In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
Androne, L., Gavan, N. A., Vereșiu, I. A., et al. (2000) · PubMed · Cited by 63
Haak, E., Usadel, K. H., Kohleisen, M., Yılmaz, A., Kusterer, K., & Haak, T. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2151 · Cited by 39
Ca, A., Vileikytė, L., Williamson, S., Al, C., & Boulton, A. J. M. (1998) · Diabetes Care · Cited by 38
Effect of Fidarestat and α‐Lipoic Acid on Diabetes‐Induced Epineurial Arteriole Vascular Dysfunction
Yorek, M. A., Coppey, L. J., Gellett, J. S., Davidson, E. P., & Lund, D. D. (2003) · Journal of Diabetes Research · doi:10.1080/15438600490277824 · Cited by 27
Cited by
Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.026 · Cited by 976
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Repurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial
Berk, J. L., Suhr, O. B., Obici, L., Sekijima, Y., Zeldenrust, S. R., Yamashita, T., Heneghan, M. A., Gorevic, P. D., Litchy, W. J., Wiesman, J. F., et al. (2013) · JAMA · doi:10.1001/jama.2013.283815 · Cited by 708
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Metadata
- Authors
- Ziegler, D., Ametov, A., Barinov, A., Dyck, P. J., Gurieva, I., Low, P. A., Munzel, U., Yakhno, N., Raz, I., Novosadova, M., Maus, J., & Samigullin, R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-11-01
- Volume
- 29
- Issue
- 11
- Pages
- 2365-2370
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2037682503
- Cited by
- 562
- References
- 33
- FWCI
- 12.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.